
|Videos|May 1, 2021
Comparing clinical outcomes of Schirmer's test with dry eye
Author(s)OTE Staff Reports
Jeffrey Gemi, MD, Ora Inc., speaks on the highlights from his presentation comparing Schirmer's test with other clinical outcomes in dry eye.
Advertisement
Jeffrey Gemi, MD, director of Special Projects, Anterior Segments, Ora Inc., speaks on the highlights from a presentation on comparing Schirmer's test with other clinical outcomes in dry eye during the virtual ARVO 2021 meeting.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Navigating antithrombotic therapy in wet AMD
2
FLORetina 2025: Port delivery system shows reliable 6-month durability and sustained efficacy in neovascular AMD for up to 7 years
3
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
4
FLORetina 2025: Multimodal deep learning for CKD diagnosis using retinal images and urine dipstick data
5













































